Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2020-11-23 Director's Dealing
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-11-23 English
FORM 10-Q
Interim / Quarterly Report Q3 2020
2020-10-28 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 28, 2020, for Innoviva, Inc. It reports the issuance of a press release regarding the company's results of operations and financial condition for the quarter ended September 30, 2020. The document explicitly states that the press release is furnished as an exhibit and is not filed as part of the report, indicating this is a current report announcing financial results rather than the full financial report itself. The Form 8-K is a regulatory filing used to announce material events, including earnings releases. Given the content and nature of the document, it fits the category of an Earnings Release (ER) announcement rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). The document length is 4096 characters, which is relatively short and consistent with an earnings release announcement rather than a comprehensive report. Therefore, the appropriate classification is Earnings Release (ER).
2020-10-28 English
FORM 4
Director's Dealing
2020-09-01 English
SCHEDULE 13D/A (AMENDMENT NO. 3)
Major Shareholding Notification
2020-09-01 English
SCHEDULE 13D/A (AMENDMENT NO. 2)
Major Shareholding Notification
2020-08-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.